The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 21 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Influenza A Virus, H1N1 Subtype  [Clear All Filters]
2020
Melidou, A., Pereyaslov D., Hungnes O., Prosenc K., Alm E., Adlhoch C., et al. (2020).  Virological surveillance of influenza viruses in the WHO European Region in 2019/20 - impact of the COVID-19 pandemic.. Euro Surveill. 25(46), 
2019
Segaloff, H., Melidou A., Adlhoch C., Pereyaslov D., Robesyn E., Penttinen P., et al. (2019).  Co-circulation of influenza A(H1N1)pdm09 and influenza A(H3N2) viruses, World Health Organization (WHO) European Region, October 2018 to February 2019.. Euro Surveill. 24(9), 
Pepin, S., Dupuy M., Borja-Tabora C. Fay Corazo, Montellano M., Bravo L., Santos J., et al. (2019).  Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccine in children aged 6-35 months: A multi-season randomised placebo-controlled trial in the Northern and Southern Hemispheres.. Vaccine. 37(13), 1876-1884.
Droogers, M., Ciotti M., Kreidl P., Melidou A., Penttinen P., Sellwood C., et al. (2019).  European Pandemic Influenza Preparedness Planning: A Review of National Plans, July 2016.. Disaster Med Public Health Prep. 13(3), 582-592.
Chatzopoulou, F., Gioula G., Kioumis I., Chatzidimitriou D., & Exindari M. (2019).  Identification of complement-related host genetic risk factors associated with influenza A(H1N1)pdm09 outcome: challenges ahead.. Med Microbiol Immunol. 208(5), 631-640.
2016
Lytras, T., Kossyvakis A., Melidou A., Andreopoulou A., Exindari M., Gioula G., et al. (2016).  Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study.. J Med Virol. 88(11), 1896-904.
Broberg, E., Melidou A., Prosenc K., Bragstad K., & Hungnes O. (2016).  Predominance of influenza A(H1N1)pdm09 virus genetic subclade 6B.1 and influenza B/Victoria lineage viruses at the start of the 2015/16 influenza season in Europe.. Euro Surveill. 21(13), 
Fleddermann, J., Diamanti E., Azinas S., Košutić M., Dähne L., Estrela-Lopis I., et al. (2016).  Virosome engineering of colloidal particles and surfaces: bioinspired fusion to supported lipid layers.. Nanoscale. 8(15), 7933-41.
2015
Melidou, A., Gioula G., Exindari M., Chatzidimitriou D., & Malisiovas N. (2015).  Genetic analysis of post-pandemic 2010-2011 influenza A(H1N1)pdm09 hemagglutinin virus variants that caused mild, severe, and fatal infections in Northern Greece.. J Med Virol. 87(1), 57-67.
Lytras, T., Kossyvakis A., Melidou A., Exindari M., Gioula G., Pogka V., et al. (2015).  Influenza vaccine effectiveness against laboratory confirmed influenza in Greece during the 2013-2014 season: a test-negative study.. Vaccine. 33(2), 367-73.
2011
Antonitsis, P., Anastasiadis K., Chalvatzoulis O., Argiriadou H., Foroulis C., Grosomanidis V., et al. (2011).  Factors associated with the development of acute heart failure in critically ill patients with severe pandemic 2009 influenza A (H1N1) infection.. Ann Thorac Surg. 91(6), 2021-2; author reply 2022.
Panagopoulou, E., Montgomery A., & Benos A. (2011).  Health promotion as a behavioural challenge: are we missing attitudes?. Glob Health Promot. 18(2), 54-7.
Tselios, K., Tsioka R., Sarantopoulos A., Mouloudi E., & Boura P. (2011).  Influenza A/H1N1 septic shock in a patient with systemic lupus erythematosus. A case report.. BMC Infect Dis. 11, 358.
Athanasiou, M., Baka A., Andreopoulou A., Spala G., Karageorgou K., Kostopoulos L., et al. (2011).  Influenza surveillance during the post-pandemic influenza 2010/11 season in Greece, 04 October 2010 to 22 May 2011.. Euro Surveill. 16(44), 
Zarogoulidis, P., Kouliatsis G., Papanas N., Spyratos D., Constantinidis T. C., Kouroumichakis I., et al. (2011).  Long-term respiratory follow-up of H1N1 infection.. Virol J. 8, 319.
Printza, N., Roilides E., Kotsiou M., Zafeiriou D., Hatzidimitriou V., & Papachristou F. (2011).  Pandemic influenza A (H1N1) 2009-associated hemolytic uremic syndrome.. Pediatr Nephrol. 26(1), 143-4.
Maltezou, H. C., Katerelos P., Mavrouli M., Lourida A., Routsias J. G., Spanakis N., et al. (2011).  Seroepidemiological study of pandemic influenza H1N1 following the 2009-2010 wave in Greece.. Vaccine. 29(38), 6664-9.
Miyakis, S., Giannakaki V., Moustakidis E., Trelopoulou A., Trakatelli C., Kotsis V., et al. (2011).  Vaccination against 2009 pandemic H1N1 influenza among healthcare workers in a tertiary hospital: rates, reasoning, beliefs.. J Hosp Infect. 78(1), 75-6.
2010
Melidou, A., Gioula G., Exindari M., Chatzidimitriou D., Diza E., & Malisiovas N. (2010).  Molecular and phylogenetic analysis of the haemagglutinin gene of pandemic influenza H1N1 2009 viruses associated with severe and fatal infections.. Virus Res. 151(2), 192-9.
Printza, N., Farmaki E., Bosdou J., Gkogka C., & Papachristou F. (2010).  Pandemic influenza A 2009 (H1N1) vaccination in high risk children with chronic renal diseases: acceptance and perceptions.. Hum Vaccin. 6(10), 819-22.
2009
Panagiotopoulos, T., Bonovas S., Danis K., Iliopoulos D., Dedoukou X., Pavli A., et al. (2009).  Cluster of new influenza A(H1N1) cases in travellers returning from Scotland to Greece - community transmission within the European Union?. Euro Surveill. 14(21), 

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.